Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies

   Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For
                  Next-Generation And Enabling Technologies

Agreements Create More Options for Farmers and Expanded Market Opportunities
for Next-Generation Technologies

PR Newswire

MONHEIM, Germany and ST. LOUIS, April 16, 2013

MONHEIM, Germanyand ST. LOUIS, April 16, 2013 /PRNewswire/ --Bayer
CropScience and Monsanto Company (NYSE: MON) have entered into a series of
licensing agreements for next-generation and enabling technologies in the
field of plant biotechnology that will provide new options and choices for

Monsanto will provide Bayer CropScience with a royalty-bearing license to
Genuity^® Roundup Ready 2 Yield^® and Genuity^® Roundup Ready 2 Xtend™
technology in soybeans in the United States and Canada. Bayer CropScience also
will receive a royalty-bearing license to Intacta RR2 PRO™ in soybeans in
Brazil with an option to a royalty-bearing license in other Latin-American
countries in the future. Bayer CropScience has also been granted
stacking-rights under certain conditions.

Under the agreements, Bayer CropScience will grant Monsanto licenses to
evaluate enabling technologies for corn rootworm control and herbicide
tolerance as options for Monsanto's future pipeline development work.

"We are excited that with the combined technologies from both companies, we
will be able to offer farmers additional pest control options and an
all-inclusive weed resistance package in soybeans. These will fit nicely with
our own technology such as LibertyLink™," said Rudiger Scheitza, member of the
board of management of Bayer CropScience and head of strategy and business
management. "We're also pleased to give Monsanto access to evaluate enabling
next-generation weed control and insect technologies for potential support of
future pipeline developments."

"We're pleased we have been able to reach an agreement with Bayer CropScience,
which will offer increased benefits for farmers and foster continued choice
and innovation in our industry," said Brett Begemann, Monsanto president and
chief commercial officer. "This agreement further supports the value of our
Genuity^® Roundup Ready 2 Yield^® platform as we prepare to enter the next
phase of innovation in soybeans with the addition of Intacta RR2 PRO™ and
Genuity^® Roundup Ready 2 Xtend™."

Additional terms and financial details of the agreements were not disclosed.

Genuity^® Roundup Ready 2 Yield^® is Monsanto's second-generation trait
technology platform for soybeans. Genuity^® Roundup Ready 2 Xtend™ soybeans
contains the Genuity^® Roundup Ready 2 Yield^® trait technology stacked with a
trait that provides tolerance to dicamba. Intacta RR2 PRO™ soybeans are the
first‐ever insect-protected trait in soybeans, providing control of
lepidopteran pests.

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health
care, agriculture and high-tech materials. This year the company looks back on
150 years of working to fulfill its mission "Bayer: Science For A Better
Life". Bayer CropScience, the subgroup of Bayer AG responsible for the
agricultural business, has annual sales of EUR 8,383 million (2012) and is one
of the world's leading innovative crop science companies in the areas of
seeds, crop protection and non-agricultural pest control. The company offers
an outstanding range of products including high value seeds, innovative crop
protection solutions based on chemical and biological modes of action as well
as an extensive service backup for modern, sustainable agriculture. In the
area of non-agricultural applications, Bayer CropScience has a broad portfolio
of products and services to control pests from home and garden to forestry
applications. The company has a global workforce of 20,800 and is represented
in more than 120 countries. This and further news is available at:

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions
and agricultural products that improve farm productivity and food quality.
Monsanto remains focused on enabling both small-holder and large-scale farmers
to produce more from their land while conserving more of our world's natural
resources such as water and energy. To learn more about our business and our
commitments, please visit: Follow our business on Twitter^®
at, on the company blog, Beyond the Rows^® at, or subscribe to our News Release RSS Feed.

Bayer Forward-Looking Statements:

This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. These
factors include those discussed in Bayer's public reports which are available
on the Bayer website at The company assumes no liability
whatsoever to update these forward-looking statements or to conform  them to
future events or developments.

Monsanto Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements,"
such as statements concerning the company's anticipated financial results,
current and future product performance, regulatory approvals, business and
financial plans and other non-historical facts. These statements are based on
current expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties, the
company's actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that could
cause or contribute to such differences include, among others: continued
competition in seeds, traits and agricultural chemicals; the company's
exposure to various contingencies, including those related to intellectual
property protection, regulatory compliance and the speed with which approvals
are received, and public acceptance of biotechnology products; the success of
the company's research and development activities; the outcomes of major
lawsuits and the previously-announced SEC investigation; developments related
to foreign currencies and economies; successful operation of recent
acquisitions; fluctuations in commodity prices; compliance with regulations
affecting our manufacturing; the accuracy of the company's estimates related
to distribution inventory levels; the company's ability to fund its short-term
financing needs and to obtain payment for the products that it sells; the
effect of weather conditions, natural disasters and accidents on the
agriculture business or the company's facilities; and other risks and factors
detailed in the company's most recent Form 10-K Report to the SEC. Undue
reliance should not be placed on these forward-looking statements, which are
current only as of the date of this release. The company disclaims any current
intention or obligation to update any forward-looking statements or any of the
factors that may affect actual results.

Genuity® Roundup Ready 2 Yield®, Genuity® Roundup Ready 2 Xtend™ and Intacta
RR2 PRO™ are trademarks or registered trademarks of Monsanto.

Monsanto Contacts Media: Sara Miller (314-694-5824)
Bayer Contacts    Media: Richard Breum (+49 2173 38-3270)

SOURCE Monsanto Company

Press spacebar to pause and continue. Press esc to stop.